在过敏性喘中调节树突细胞功能,使用Toxoplasma gondii血清蛋白酶抑制剂1 1
Joel Katan Piñeiro1, Ariadna Soledad Soto2, Ana Farias3
1Centro de Estudios en Salud y Medio Ambiente, ITECA, ECyT, UNSAM, CONICET, Buenos Aires, Argentina.
International immunology
|June 9, 2025
概括
复合性Toxoplasma gondii血清蛋白酶抑制剂1 (rTgPI-1) 促进了宽容性树突细胞 (DCs) 和调节性T细胞,为过敏免疫疗法提供了潜力. 这种辅助疗法减少了小鼠和人类细胞的过敏反应.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 疫苗辅助剂 疫苗辅助剂
背景情况:
- 耐药辅助剂对于提高过敏疫苗疗效至关重要.
- 之前的研究表明,当与卵泡胺一起注射入鼻时,rTgPI-1可缓解小鼠的喘症状.
研究的目的:
- 研究rTgPI-1的免疫调节机制,特别是对树突细胞 (DC) 的影响.
- 评估rTgPI-1作为特定过敏原免疫疗法的辅助剂的潜力.
主要方法:
- 骨髓衍生DCs (BMDCs) 用rTgPI-1生成并分析其表型和功能.
- 在体内研究中,在喘小鼠模型中,rTgPI-1与过敏原的鼻内同时使用.
- 来自虫过敏患者的外周血液单核细胞 (PBMC) 被在rTgPI-1的存在下用家用粉尘虫提取物刺激.
主要成果:
- rTgPI-1 治疗的 BMDC 呈现出半成熟的,耐受性表现型,共刺激分子和细胞因子配置表达变化 (较高的 IL-10/IL-12 比率).
- 这些DC诱导T细胞增殖减少,IL-17和IL-4分泌减少,CD4+FoxP3+调节性T细胞增加.
- 在体内,rTgPI-1减少了特定的DC子集,扩大了肺调节T细胞,并在患者PBMC中抑制了过敏原特异性IL-4和IL-5分泌.
- 合成抑制剂纳法莫斯甲基酸盐没有诱导类似的宽容效应,突出显示了rtgPI-1的独特活性.
结论:
- rTgPI-1促进了宽容性DC表型,抑制了T细胞激活,并促进了调控性T细胞分化.
- rTgPI-1在体内选择性调节直流子集,从而促进其治疗效果.
- 这些发现支持rTgPI-1的潜力,作为一种新的辅助剂,用于过敏原特异性免疫疗法的临床前开发.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K


